This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Frank L. Meleney, M.D.
New York (32)

AMA Arch Intern Med. 1953;91(3):414.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor::

—The review of the booklet on bacitracin which appears on page 424 of the September issue of the ARCHIVES OF INTERNAL MEDICINE has recently been brought to my attention. I should like to point out some fallacies in that review.

The reviewer says that there are "many statements in this book which are hardly warranted on the basis of present-day knowledge," but he has not pointed out one such statement. Those that he uses as illustrations are inaccurate. Contrary to what the reviewer has stated, the book covers fully all of the studies on the nephrotoxic element in bacitracin reported up to the time of publication. Furthermore, nowhere in the book is the statement made that bacitracin is the treatment of choice in amebiasis.

Contrary to what the reviewer has stated, (1) nephrotoxicity was of minor importance in the last 250 cases reported; (2) the purity of . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?